MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2023 International Congress

    Development of an Item Bank for Assessing Psychosis in Parkinson’s Disease: A Systematic Review

    G. Mangone, M. Tosin, C. Goetz, G. Stebbins, T. Mestre (Chicago, USA)

    Objective: This study aimed to develop an item bank for assessing psychosis in Parkinson's disease (PD). Background: Psychosis is a common and debilitating symptom in…
  • 2023 International Congress

    Sleep disorders and their relationship to non-motor symptoms in Mexican Parkinson’s disease patients

    D. Aguila-Godinez, A. Herrera Ruiz, E. Santiago, L. Lira Juarez, MA. Medrano Delgado, M. Ruiz Mafud, A. Hernandez-Medrano, A. Regalado Mustafa, G. Cerda Hernandez, M. Rodriguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Dominguez Garcia, D. Romero-Teran, K. Talvera-Lagunas, M. Medina Perez (Mexico City, Mexico)

    Objective: Analyze the impact of sleep disorders (SD) on the severity of non-motor symptoms (NMS) in Parkinson’s Disease (PD) patients Background: Sleep is a physiological…
  • 2023 International Congress

    Development and preliminary results of a new picture-based self-rating tool for neuropsychiatric syndromes in Parkinson’s disease

    S. Simon, JC. Baldermann, K. Böttcher, S. Meißner, C. Schedlich-Teufer, D. Gruber, D. Podes, LS. Neumaier, E. Kalbe, GR. Fink, G. Ebersbach, W. Jost, M. Barbe, J. Kessler, ST. Jost (Cologne, Germany)

    Objective: To develop a picture-based, non-verbal screening tool to detect neuropsychiatric syndromes (NPS), including depression, anxiety, apathy, fatigue, mania, impulse control disorder (ICD), sleeping problems,…
  • 2023 International Congress

    Association between subjective and objective language measures in DBS candidates

    T. Turner, L. Blackett, F. Rodriguez-Porcel (Charleston, USA)

    Objective: Determine if expressive language measures from neuropsychological testing correspond to subjective communication struggles in Deep Brain Stimulation (DBS) candidates. Background: A number of studies…
  • 2023 International Congress

    Comparison in the disability level according to WHODAS 2 between people living with Early and Late Onset Parkinson’s Disease

    M E. Pimentel Piemonte, K. Costa Nobrega, I. Silva Nascimento, B. Antunes Souza, I. Carneiro Barone, G. Checchio, V. Pereira Ponciano, C. Cerveira Paula, A. Nunes Possani, N. Cardos Penha (Sao Paulo, Brazil)

    Objective: To compare disability levels according to WHODAS-2 between people living with EOPD and people living with LOPD. Background: Although Parkinson's disease (PD) is more…
  • 2023 International Congress

    Motor subtype stability and cognitive profiles in early Parkinson’s disease

    N. Chia, S. Ng, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)

    Objective: To examine the association between motor subtypes’ stability and cognitive assessment scores across three years in early Parkinson’s disease (PD). Background: Past studies have…
  • 2023 International Congress

    Efficacy of melatonin in patients with insomnia and Parkinson’s disease

    A. Domínguez-García, DR. Aguila-Godinez, AA. Herrera-Ruiz, EC. Santiago-Delacruz, LG. Lira-Juárez, MAG. Medrano-Delgado, MA. Ruiz-Mafud, AJ. Hernández-Medrano, AY. Regalado-Mustafá, DP. Romero-Terán, MF. Medina-Pérez, GI. Cerda-Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez-Armesto, A. Abundes-Corona, A. Alcocer-Salas, K. Talavera-Lagunas (CDMX, Mexico)

    Objective: Determine the efficacy of melatonin in patients with Parkinson's disease suffering from insomnia. Background: Parkinson disease (PD) is a degenerative disease manifested by motor…
  • 2023 International Congress

    Impact of deep brain stimulation of the subthalamic nuclei on non-motor symptoms in Parkinson’s disease: a monocentric prospective study with a 12-month follow-up

    V. Leclercq, V. Donckels, E. Hanon, S. Dethy (Sint-Pieters-Leeuw, Belgium)

    Objective: The aim of the study is to evaluate the evolution of non-motor symptoms in Parkinson's disease (PD) in patients treated with deep brain stimulation…
  • 2023 International Congress

    A comparative analysis of vegetative disorders in Parkinson`s disease and vascular parkinsonism.

    R. Juraev, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparative analysis of vegetative disorders (VD)  in Parkinson's disease and vascular parkinsonism. Background: Vegetative disorders (VD) are one of the most common nonmotor disorders…
  • 2023 International Congress

    Reduced non-REM sleep in Parkinson disease is associated with memory impairment and non-motor symptom burden

    S. Shah, C. Dintino, S. Lageman, N. Mukhopadhyay, E. Shelton, S. Holden, J. Broussard, L. Cloud, M. Barrett, B. Berman (Richmond, USA)

    Objective: To evaluate the relationship between sleep architecture and cognitive function in Parkinson disease (PD). Background: About half of PD patients develop mild cognitive impairment…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley